Bone Biologics Corp
BBLGNasdaqCIK 1419554HealthcareFiscal year ends Dec 31
Reports and events: 214 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-2007:46 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-041982 |
| 2023-11-2007:00 ET | DEF 14A | Proxy statementPeriod 2023-11-20 | 0001493152-23-041973 |
| 2023-11-2006:50 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001493152-23-041971 |
| 2023-11-1416:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-041059 |
| 2023-10-2406:06 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001493152-23-038029 |
| 2023-09-2917:19 ET | 8-K | 3.01 Delisting notice | 0001493152-23-034907 |
| 2023-09-1216:01 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-032347 |
| 2023-08-1415:17 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028330 |
| 2023-08-0306:15 ET | DEF 14A | Proxy statementPeriod 2023-08-03 | 0001493152-23-026502 |
| 2023-07-0516:41 ET | 8-K | 8.01 Other events | 0001493152-23-023458 |
| 2023-06-1614:53 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-021605 |
| 2023-06-1306:04 ET | S-1/A | Registration statement, amended | 0001493152-23-020997 |
| 2023-06-0617:19 ET | S-1/A | Registration statement, amended | 0001493152-23-020316 |
| 2023-06-0613:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-020241 |
| 2023-05-1916:35 ET | 8-K | 3.01 Delisting notice | 0001493152-23-018373 |
| 2023-05-1516:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017393 |
| 2023-05-0117:24 ET | S-1 | Registration statement | 0001493152-23-015035 |
| 2023-03-3016:51 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-009799 |
| 2023-03-2916:57 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-23-009501 |
| 2022-12-2116:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-036161 |
| 2022-11-2116:29 ET | 8-K | 3.01 Delisting notice | 0001493152-22-033115 |
| 2022-11-1406:32 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031540 |
| 2022-10-2509:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-029492 |
| 2022-10-1306:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-028300 |
| 2022-10-1116:59 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-028136 |
| 2022-10-0518:17 ET | S-1/A | Registration statement, amended | 0001493152-22-027628 |
| 2022-10-0406:16 ET | S-1/A | Registration statement, amended | 0001493152-22-027481 |
| 2022-09-2316:58 ET | S-1 | Registration statement | 0001493152-22-026702 |
| 2022-08-2420:23 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-023895 |
| 2022-08-1111:44 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-021997 |
| 2022-07-0611:18 ET | DEF 14A | Proxy statementPeriod 2022-07-06 | 0001493152-22-018642 |
| 2022-06-0917:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-016325 |
| 2022-05-2311:16 ET | 8-K | 5.08 Item not in the standard list | 0001493152-22-014716 |
| 2022-05-1311:49 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013230 |
| 2022-03-1515:19 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-006850 |
| 2022-03-0806:06 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-006230 |
| 2021-12-2213:51 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-21-032259 |
| 2021-11-1512:38 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028429 |
| 2021-11-0106:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-21-026809 |
| 2021-10-1916:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-025784 |
| 2021-10-1506:05 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-025492 |
| 2021-10-0717:31 ET | S-1/A | Registration statement, amended | 0001493152-21-024979 |
| 2021-10-0617:16 ET | S-1/A | Registration statement, amended | 0001493152-21-024833 |
| 2021-08-3016:36 ET | S-1/A | Registration statement, amended | 0001493152-21-021565 |
| 2021-08-1613:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-020020 |
| 2021-06-2817:19 ET | S-1 | Registration statement | 0001493152-21-015404 |
| 2021-06-0715:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-21-013724 |
| 2021-05-2115:19 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-012491 |
| 2021-04-1516:31 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001493152-21-008887 |
| 2021-04-1516:22 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001493152-21-008878 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:46 ET. Listed shows no prices and gives no investment advice.